3/15/24 16:03 | 3/13/24 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | M.d | 656 | 4.72 | 0 | 139 | 52 | 407 | D | | | | | | | | | | | | | | |
12/11/23 19:03 | 12/11/23 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | M.d | 324 | 5.00 | 0 | 65 | 61 | 171 | D | | | | | | | | | | | | | | |
12/11/23 19:03 | 12/11/23 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | S.d | -1,297 | 20.00 | 0 | -65 | -27 | 171 | D | | | | | | | | | | | | | | |
10/10/23 17:04 | 10/9/23 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | M.d | 324 | 5.00 | 0 | 65 | 61 | 171 | D | | | | | | | | | | | | | | |
10/10/23 17:04 | 10/9/23 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | S.d | -921 | 14.20 | 0 | -65 | -27 | 171 | D | | | | | | | | | | | | | | |
6/7/22 08:14 | 6/6/22 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | P | 100 | 1.95 | 0 | 51 | 43 | 171 | D | | | | | | | | | | | | | | |
10/15/19 08:20 | 10/10/19 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | P | 22 | 4.30 | 0 | 5 | 4 | 120 | D | | | | | | | | | | | | | | |
9/24/19 08:56 | 9/20/19 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | P.m | 28 | 5.53 | 0 | 5 | 5 | 115 | D | | | | | | | | | | | | | | |
12/21/18 17:11 | 12/21/18 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | P | 65 | 6.54 | 0 | 10 | 10 | 110 | D | | | | | | | | | | | | | | |
10/16/18 06:21 | 10/15/18 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | P | 50 | 9.90 | 0 | 5 | 5 | 100 | D | | | | | | | | | | | | | | |
7/30/18 06:05 | 7/27/18 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | P | 55 | 10.90 | 0 | 5 | 6 | 95 | D | | | | | | | | | | | | | | |
5/15/18 08:08 | 5/11/18 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | CEO | P | 53 | 10.65 | 0 | 5 | 6 | 90 | D | | | | | | | | | | | | | | |
7/24/17 06:15 | 7/20/17 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | DO | Interim | P | 73 | 7.34 | 0 | 10 | 13 | 85 | D | | | | | | | | | | | | | | |
4/6/16 16:21 | 4/4/16 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | O | CFO | P.m | 76 | 1.39 | 1 | 55 | 275 | 75 | D | -83 | -80 | -33 | -24 | 20 | 6 | 1 | 2 | 29 | 15 | 80 | 18 | 38 | 184 |
5/19/15 19:41 | 5/18/15 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shah Sujal | CA | O | CFO | P | 34 | 3.40 | 0 | 10 | 100 | 20 | D | | -58 | -57 | -73 | -49 | -26 | -14 | 16 | 32 | 14 | -12 | -20 | -56 | -26 |